Priority Medical

BIOTECHNOLOGY

How Startups Are Taking on Tech Giants with Fresh Funding?
BIOTECHNOLOGY

How Startups Are Taking on Tech Giants with Fresh Funding?

In a landscape dominated by tech giants, it's refreshing to see startups rising to the challenge with massive funding rounds. This trend has been particularly evident in the AI sector, where companies like KoBold Metals, Auger, Basecamp Research, and Alan are leveraging cuttingedge technology to compete against industry behemoths..

Covea Finance Purchases 59,100 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
BIOTECHNOLOGY

Covea Finance Purchases 59,100 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

Title Covea Finance Buys 59,100 Shares of BioMarin Pharmaceutical Inc., Increasing Its Holdings by 328.3% BioMarin Pharmaceutical Inc..

The Manufacturers Life Insurance Company Acquires 32,846 Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA)
BIOTECHNOLOGY

The Manufacturers Life Insurance Company Acquires 32,846 Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA)

By: Newspaper Journalist In a significant move in the world of pharmaceuticals, The Manufacturers Life Insurance Company has increased its stake in Centessa Pharmaceuticals plc (NASDAQ:CNTA) by 30.4%, acquiring a substantial 32,846 shares. This strategic expansion highlights the growing interest in Centessa’s innovative approach to medicine and its promising pipeline of treatments..

Medical Breakthroughs

EverGlade Consulting Helps Cirsium Secure up to $61 Million in ARPA-H Funding

Houston, TX – EverGlade Consulting, a national consulting firm specializing in securing federal funding for groundbreaking health research, has played a pivotal role in helping Cirsium Biosciences sec.

EverGlade Consulting Helps Cirsium Secure up to $61 Million in ARPA-H Funding
Pharmaceutical

Regeneron Pharmaceuticals Insiders Sell US$26m Of Stock, Possibly Signalling Caution

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has been a significant player in the biotechnology industry, known for its innovative treatments and therapies.

Regeneron Pharmaceuticals Insiders Sell US$26m Of Stock, Possibly Signalling Caution

Subscribe to Our Newsletter

Stay up-to-date with our latest news, articles, and exclusive offers. Join our community and never miss an important update!

Follow Us